Table 2 Costs, frequency of health care use, and days of illness before (states A–C) and after (states D and E) having coeliac disease diagnosis
From: Is mass screening for coeliac disease a wise use of resources? A health economic evaluation
Health care visits | Hospitalisation days | Days of illness | ||||
|---|---|---|---|---|---|---|
Cost per visit (euro) | 311.9 | 1136.9 | 153a | |||
Age groupb | ≤ 65 | > 65 | ≤ 65 | > 65 | ≤ 65 | > 65 |
Frequency for state | ||||||
A—Symptom-free | 3.7 | 5.1 | 0.7 | 1.0 | 2.5 | 0 |
B—Symptoms | 3.7 | 5.1 | 0.7 | 1.0 | 3.7 | 0 |
C—Clinical evaluation | 5.4 | 5.4 | 2.3 | 2.9 | 7.2 | 0 |
D—Compliant | 3.7 | 5.1 | 0.7 | 1.0 | 2.5 | 0 |
E—Non-compliant | 4.5 | 5.3 | 1.5 | 2.0 | 4.9 | 0 |